Skip to main content
Equibles
ENTA logo

ENTA · Enanta Pharmaceuticals Inc · Proposed Sales

Track ENTA — free

Use ENTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.70 -0.48 (-3.95%) Q2 2024 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$354.75M
Shares
29.13M
Volume · Oct 28 282.01K Avg daily vol (3M) 245.01K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-12-05 Luly Jay R. 4,743
2024-07-11 Scott T. Rottinghaus 11,945
2024-06-17 Tara Lynn Kieffer 7,266
2023-12-12 Vance Terry 15,295
Showing 1–4 of 4 filings
Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 15 filings 15 filers Visit website Investor relations